Danish Medical Research ApS — Credit Rating and Financial Key Figures
CVR number: 39630583
Valseholmen 11, 2650 Hvidovre
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -3.39 | -63.90 | -0.09 | -14.34 | -8.10 |
| EBIT | -3.39 | -63.90 | -27.28 | -14.34 | -8.10 |
| Other financial expenses | -1.21 | -0.78 | -0.13 | -0.09 | |
| Pre-tax profit | -4.60 | -64.68 | -27.41 | -14.43 | -8.10 |
| Net earnings | -4.60 | -64.68 | -27.41 | -14.43 | -8.10 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 2.00 | 8.90 | |||
| Short term receivables total | 2.00 | 8.90 | |||
| Cash and bank deposits | 57.76 | 25.04 | 11.23 | 14.10 | 8.50 |
| Cash and cash equivalents | 57.76 | 25.04 | 11.23 | 14.10 | 8.50 |
| Balance sheet total (assets) | 59.76 | 25.04 | 20.13 | 14.10 | 8.50 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 24.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -59.65 | 8.84 | -55.85 | -83.26 | -97.69 |
| Profit of the financial year | -4.60 | -64.68 | -27.41 | -14.43 | -8.10 |
| Shareholders equity total | -40.25 | -15.85 | -43.26 | -57.69 | -65.78 |
| Non-current liabilities total | |||||
| Current trade creditors | 2.50 | ||||
| Current owed to participating | 40.22 | 40.70 | 63.39 | 71.79 | 71.79 |
| Other non-interest bearing current liabilities | 59.79 | 0.18 | 0.00 | ||
| Current liabilities total | 100.01 | 40.88 | 63.39 | 71.79 | 74.29 |
| Balance sheet total (liabilities) | 59.76 | 25.04 | 20.13 | 14.10 | 8.50 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.